FDA Investigator Daniel J Min
Daniel J Min has inspections in 1 countries as of 20 Sep 2023. Daniel J Min has collaborated with a combinined 1410 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adetutu M Gidado,
Alice S Tsao,
Alison N Correll,
Alison N Stieg,
Allison A Aldridge, PhD,
Amit Kokate,
Amy Chen,
Amy N Chen,
Anastasia I Offordile,
Anastasia M Shields,
Anita R Michael,
Ankur C Patel,
Audrey Thereset Uy,
Barbara Jwilimczyk Macri,
Brandy N Lepage,
Christina K Theodorou,
Craig D Zagata,
Cynthia A Palmer,
Daniel J Deciero,
Daniel Min,
David A Oluwo,
Deborah J Parris,
Douglas C Kovacs,
Elaine E Gilfillan,
Emmanuel J Ramos,
Erin D Mccaffery,
Fred Razzaghi,
Frederick Razzack,
Frederick Razzaghi,
Gayle S Lawson,
Hala L Selby,
Helen Verdel,
James M Mason,
James R Birkenstamm,
Janet A Rajan,
Jogy George,
Jonathan G Matrisciano,
Joy Rkozlowski Klena,
Juanita P Versace,
Junho Pak,
Karen E D'orazio,
Kendra L Brooks,
Ko U Min,
Lata C Mathew, PhD,
LCDR Margaret E Digennaro,
Luis A Dasta,
Marcellinus D Dordunoo,
Margaret Faulkner,
Maria A Reed,
Matthew R Noonan,
Melissa T Roy,
Michael A Taylor,
Michael J Nerz,
Michael L Casner,
Michael R Klapal,
Nancy F Scheraga,
Nancy M Espinal,
Natasha Gupta,
Nicholas A Violand,
Niketa Patel,
Odera I Ekwunife,
Paul L Bellamy,
Pushpa S Jayasekara,
Qin Xu,
Rachael O Oyewole,
Raffi B Papazian,
Rose Ljean Mary,
Russell J Glapion,
Saleem A Akhtar,
Sam Pepe,
Sayyem H Akbar,
Stephanie Mangigian, MS/OSH, RN,
Tajah L Blackburn,
Tammy L Chavis,
Tanya R Syffrard,
Tekalign Wondimu,
Thomas E Friel,
Tiffani D Wilson,
Tonia F Bernard,
Vlada Matusovsky,
Youmin Wang
Daniel J Min's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2021 | FDA 483 | Dercher Enterprises, Inc., DBA Gordon Laboratories - Form 483, 2021-05-04 |
August, 2022 | EIR | New Dawn Manufacturing - EIR, 2022-08-29 |
March, 2023 | FDA 483 | I 3 PHARMACEUTICALS, LLC - Form 483, 2023-03-03 |
July, 2021 | FDA 483 | ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483, 2021-07-01 |
December, 2022 | FDA 483 | Northern VA Compounders PLLC - Form 483, 2022-12-09 |
July, 2023 | FDA 483 | Medical Products Laboratories, Inc. - Form 483, 2023-07-13 |
May, 2022 | FDA 483 | Ferring Production Inc. - Form 483, 2022-05-12 |
April, 2023 | FDA 483 | AustarPharma, LLC - Form 483, 2023-04-05 |
June, 2022 | FDA 483 | Mandell's Clinical Pharmacy - Form 483, 2022-06-17 |
February, 2022 | FDA 483 | I 3 PHARMACEUTICALS, LLC - Form 483, 2022-02-22 |
December, 2021 | FDA 483 | Sigmapharm Laboratories, LLC - Form 483, 2021-12-07 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more